0001415889-23-011318.txt : 20230719
0001415889-23-011318.hdr.sgml : 20230719
20230719161002
ACCESSION NUMBER: 0001415889-23-011318
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230718
FILED AS OF DATE: 20230719
DATE AS OF CHANGE: 20230719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LaBarre Michael J.
CENTRAL INDEX KEY: 0001507174
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32335
FILM NUMBER: 231096808
MAIL ADDRESS:
STREET 1: 11388 SORRENTO VALLEY ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HALOZYME THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001159036
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 880488686
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12390 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 794-8889
MAIL ADDRESS:
STREET 1: 12390 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: HALOZYME THERAPEUTICS INC
DATE OF NAME CHANGE: 20040312
FORMER COMPANY:
FORMER CONFORMED NAME: GLOBAL YACHT SERVICES INC
DATE OF NAME CHANGE: 20010912
4
1
form4-07192023_080758.xml
X0508
4
2023-07-18
0001159036
HALOZYME THERAPEUTICS, INC.
HALO
0001507174
LaBarre Michael J.
C/O HALOZYME THERAPEUTICS, INC.
12390 EL CAMINO REAL
SAN DIEGO
CA
92130
false
true
false
false
SVP, CHIEF TECHNICAL OFFICER
1
Common Stock
2023-07-18
4
M
0
10000
18.41
A
151911
D
Common Stock
2023-07-18
4
S
0
10000
40.43
D
141911
D
Common Stock
2023-07-18
4
M
0
7175
13.81
A
149086
D
Common Stock
2023-07-18
4
M
0
2825
8.11
A
151911
D
Option to Purchase Common Stock
18.41
2023-07-18
4
M
0
10000
0
D
2028-02-14
Common Stock
10000
7505
D
Option to Purchase Common Stock
13.81
2023-07-18
4
M
0
7175
0
D
2025-02-04
Common Stock
7175
26825
D
Option to Purchase Common Stock
8.11
2023-07-18
4
M
0
2825
0
D
2026-02-03
Common Stock
2825
75627
D
The option exercise and sale reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.
Represents a weighted average sales price per share. These shares were sold at prices ranging from $40.10 to $40.84. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Represents an acquisition of 7,175 shares by the Reporting Person pursuant to a cash exercise and hold transaction.
Represents an acquisition of 2,825 shares by the Reporting Person pursuant to a cash exercise and hold transaction.
This option was granted on February 14, 2018 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.
This option was granted on February 4, 2015 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.
This option was granted on February 3, 2016 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.
/s/ James R. Oehler, Attorney-in-Fact
2023-07-19